Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patients with Complicated Parapneumonic Effusions (CPE) or empyema (American Journal of Respiratory and Critical Care Medicine, 2019)

(untitled) - Komissarov, A; Florova, G; Beckert, L; Brockway, B; Simpson, G; Southcott, A; Lee, Y; Rahman, N; Light, R; Shoemaker, S; Gillies, J; Sarva, K; et al.